聂德权:截至中午已有6万人预约接种新型肺炎疫苗
公务员事务局局长聂德权指,截至今日(23日)11时45分至中午约12时,已有约6万人预约接种新型肺炎疫苗,占未来两星期名额约80%,今日开始运作的首批五间社区疫苗接种中心目前尚余少量名额。
他解释,每个中心有15个接种站,中心每日可接种约2,500剂疫苗,但考虑到科兴疫苗需在28日後接种第二剂,市民在接种第一剂後将即时在中心预约第二次接种时间,因此起始并未开放之後日期供市民预约,以免接种时间混乱。
他透露,除於接种中心提供接种服务外,疫苗亦会供予全港约1,500间诊所,今日将与私家医生进行简介会,若安排好就尽快开放於诊所接种疫苗,另预期复必泰疫苗今个星期稍後时间抵港。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.